Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.

UEI: EFXWC4X2XJ91CAGE: 5MVV0

GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC. is a federal contractor, registered under UEI EFXWC4X2XJ91 and CAGE code 5MVV0. It has been awarded $10,530,949 in federal contracts. Primary work spans Blood and Organ Banks. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

EFXWC4X2XJ91

CAGE Code

5MVV0

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621991Blood and Organ Banks(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Greater Metropolitan Community Blood Service, Inc. specializes in the procurement, storage, processing, and distribution of blood products and blood components to support critical healthcare needs within federal medical systems. Their core capabilities center on maintaining a reliable, compliant sup...

Greater Metropolitan Community Blood Service, Inc. specializes in the procurement, storage, processing, and distribution of blood products and blood components to support critical healthcare needs within federal medical systems. Their core capabilities center on maintaining a reliable, compliant supply chain for whole blood, red blood cells, platelets, plasma, and other transfusion-ready components, ensuring adherence to AABB and FDA standards for safety, traceability, and shelf-life management. The organization demonstrates deep technical expertise in cold chain logistics, blood banking operations, donor screening protocols, and just-in-time delivery to multi-site healthcare facilities, with a strong focus on meeting the high-acuity demands of veteran care environments. Their operational model emphasizes quality control, inventory optimization, and real-time inventory tracking systems to minimize waste and ensure readiness for emergency and routine transfusion requirements. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, providing essential blood products to VISN 2 Downstate participating sites. This recurring engagement reflects a trusted partnership built on reliable delivery, regulatory compliance, and mission-critical service continuity for VA medical centers and outpatient clinics. Their primary industry focus is within NAICS 621991 — Blood and Organ Banks — where they function as a specialized blood services provider for government healthcare networks. They are positioned as a mission-aligned vendor in the federal blood supply ecosystem, serving high-volume, regulated medical facilities that require assured access to safe, screened, and properly stored blood components. The entity is structured as an 8H concern and is headquartered in Yonkers, New York. While no federal certifications are listed, their sustained performance with the VA underscores operational maturity and alignment with federal healthcare procurement standards. Their geographic presence supports a regional footprint with national relevance in the federal blood services market.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

44

All time

Active

1

Currently performing

Completed

43

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Type Over Time
Award Size Distribution
Awards by Place of Performance

Compete with GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS

Open opportunities in GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.'s top NAICS codes and agencies

NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Notice of Funding Opportunity (RFA-CA-28-004) for a limited competition to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain national resources for the collection, processing, storage, and distribution of clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the investigation of drug response and resistance mechanisms. The NCI intends to fund approximately six awards with a total program funding of $19 million for fiscal year 2027, with a maximum direct cost limit of $3.0 million per year and a requested project period of six years. Applications are evaluated based on scientific and technical merit through the NIH peer-review system, focusing on significance, environment, and the likelihood of the project to exert a sustained influence on the research field. Eligible organizations must maintain active SAM and eRA Commons registrations and provide specific documentation, including the current scale of operation, accomplishments, and standard operating procedures. Awardees are required to implement robust quality assurance programs, adhere to Federal Human Subjects Regulations under 45 CFR 46, and follow strict cybersecurity incident reporting protocols, including notifying the HHS within 48 hours of discovery. There is no set-aside status specified for this opportunity.
National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details